The 12 references in paper A. Smirnov V., V. Dobronravov A., I. Kayukov G., А. Смирнов В., В. Добронравов А., И. Каюков Г. (2005) “КАРДИО-РЕНАЛЬНЫЙ КОНТИНУУМ: ПАТОГЕНЕТИЧЕСКИЕ ОСНОВЫ ПРЕВЕНТИВНОЙ НЕФРОЛОГИИ // CARDIORENAL CONTINUUM, PATHOGENETICAL GROUNDS OF PREVENTIVE NEPHROLOGY” / spz:neicon:nefr:y:2005:i:3:p:7-15

1
Смирнов АВ, Каюков ИГ, Есаян АМ, Добронравов ВА, Кучер АГ, Тугушева ФА. Превентивный подход в современной нефрологии. Нефрология 2004; 8(3): 7-14
(check this in PDF content)
2
Perera GA. Hypertensive vascular disease: description and natural history. J Chron Dis 1955; 1: 33-42
(check this in PDF content)
3
Кузьмин ОБ, Пугаева МО, Чуб СВ. Легкая дисфункция почек у больных с эссенциальной гипертонией: клинические проявления и лекарственная терапия. Нефрология 2004; 8(3): 15-21
(check this in PDF content)
4
Смирнов АВ, Есаян АМ, Каюков ИГ. Хроническая болезнь почек: на пути к единству представлений. Нефрология 2002; 6(4): 11-17
(check this in PDF content)
5
National Kidney Foundation KD: Clinical practice guidelines for chronic kidney disease: Evaluation, classification and stratification. Am J Kidney Dis 2002; 39 [Suppl 1]: S1-S266
(check this in PDF content)
6
Ruelope ZM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001; 12: 218-225
(check this in PDF content)
7
Brown MJ, Palmer CR, Castaigne A et al. Morbidity and mortality in patients randomized to double-blind treatment with long-acting calcium-channel blocker or diuretic in International Nifidipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000: 356 (9228): 366-372
(check this in PDF content)
8
Haroun NK, Jaar BG, Hoffman SC et al. Risk factors for chronic kidney disease: a prospective study of 23.534 men and women in Washington Country, Maryland. J Am Soc Nephrol 2003; 14: 2934- 2941
(check this in PDF content)
9
U.S. Renal Data System. USDRS 2001. Annual Data Report, Bethesda, M.D., National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. 2001
(check this in PDF content)
10
Ritz E, Dikow R, Ruilope LM. Renal dysfunction as a cardiovascular risk factor. Curr Hypertens Rep 2002; 4: 365368
(check this in PDF content)
11
Смирнов АВ, Добронравов ВА, Бодур-Ооржак АШ и др. Эпидемиология и факторы риска хронических болезней почек: региональный уровень общей проблемы. Тер арх 2005; 77(6): 20-27
(check this in PDF content)
12
Halimi JM, Forhan A, Balkan B et al. Is microalbuminuria an integrated risk marker for cardiovascular disease and insulin resistance in both men and women? J Cardiovasc Risk 2001; 8:
(check this in PDF content)